InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Daly Jason B.. Director active across 1 company, notably Amneal Pharmaceuticals, Inc.. In total, 11 disclosures have been published. Breakdown: 0 buy · 6 sells. Total volume traded: €4.3m. History available since 3 March 2023. The latest transaction was filed on 11 August 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations
Daly Jason B. is EVP, Chief Legal Officer at Amneal Pharmaceuticals, Inc. He has 9 filings in total, and across the 9 sampled filings between 2023-03-07 and 2026-03-05, the activity is mainly sales, for a total of EUR 996157, with Levée d'options as the most frequent transaction nature.